Drug Profile
KN 006
Alternative Names: KN-006Latest Information Update: 28 Aug 2019
Price :
$50
*
At a glance
- Originator Alphamab
- Developer Jiangsu Alphamab Biopharmaceuticals
- Class Infertility therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Infertility
Most Recent Events
- 28 Aug 2019 No recent reports of development identified for phase-I development in Infertility in China
- 22 Jul 2016 Phase-I clinical trials in Infertility in China (unspecified route) (Alphamab pipeline, July 2016)
- 07 May 2015 Preclinical trials in Infertility in China (unspecified route)